Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1138

1.

BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells.

Debruyne DN, Dries R, Sengupta S, Seruggia D, Gao Y, Sharma B, Huang H, Moreau L, McLane M, Day DS, Marco E, Chen T, Gray NS, Wong KK, Orkin SH, Yuan GC, Young RA, George RE.

Nature. 2019 Aug 7. doi: 10.1038/s41586-019-1472-0. [Epub ahead of print]

PMID:
31391581
2.

Effect of Time of Day of Infection on Chlamydia Infectivity and Pathogenesis.

Lundy SR, Ahmad T, Simoneaux T, Benyeogor I, Robinson Y, George Z, Ellerson D, Kirlin W, Omosun T, Eko FO, Black CM, Blas-Machado U, DeBruyne JP, Igietseme JU, He Q, Omosun YO.

Sci Rep. 2019 Aug 6;9(1):11405. doi: 10.1038/s41598-019-47878-y.

3.

Bone-targeted therapy in castration-resistant prostate cancer: where do we stand?

Gómez Rivas J, Carrion DM, Alvarez-Maestro M, Cathelineau X, Sanchez-Salas R, Di Lorenzo G, Di Maio M, Paul A, Martinez-Piñeiro L, Sartor O, Saad F, Debruyne F.

Minerva Urol Nefrol. 2019 Jul 25. doi: 10.23736/S0393-2249.19.03420-9. [Epub ahead of print]

PMID:
31353876
4.

An observational pilot study to evaluate the feasibility and quality of oncological home-hospitalization.

Cool L, Missiaen J, Vandijck D, Lefebvre T, Lycke M, De Jonghe PJ, Vergauwe P, Foulon V, Pottel H, Debruyne P, Van Eygen K.

Eur J Oncol Nurs. 2019 Jun;40:44-52. doi: 10.1016/j.ejon.2019.03.003. Epub 2019 Mar 23.

PMID:
31229206
5.

Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial.

Cambron M, Mostert J, D'Hooghe M, Nagels G, Willekens B, Debruyne J, Algoed L, Verhagen W, Hupperts R, Heersema D, De Keyser J; FLUOX-PMS Study Group.

Mult Scler. 2019 Jun 20:1352458519843051. doi: 10.1177/1352458519843051. [Epub ahead of print]

PMID:
31218911
6.

Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11.

Reza M, Wirth M, Tammela T, Cicalese V, Veiga FG, Mulders P, Miller K, Tubaro A, Debruyne F, Patel A, Caris C, Witjes W, Thorsson O, Wollmer P, Edenbrandt L, Ohlsson M, Trägårdh E, Bjartell A.

Eur Urol Oncol. 2019 Jun 8. pii: S2588-9311(19)30069-0. doi: 10.1016/j.euo.2019.05.002. [Epub ahead of print]

PMID:
31186177
7.

Conversation in cardiology: Is there a need for clinical trials for the nonhyperemic pressure ratios?

Kern MJ, Berry C, deBruyne B, Fearon W, Jeremias A, Johnson N, Kandzari D, Kirtane A, Moses J, Krucoff M, Stone G.

Catheter Cardiovasc Interv. 2019 Aug 1;94(2):227-232. doi: 10.1002/ccd.28336. Epub 2019 May 20. No abstract available.

PMID:
31111644
8.

Screening Methods for Age-Related Hearing Loss in Older Patients with Cancer: A Review of the Literature.

Lycke M, Lefebvre T, Cool L, Van Eygen K, Boterberg T, Schofield P, Debruyne PR.

Geriatrics (Basel). 2018 Aug 2;3(3). pii: E48. doi: 10.3390/geriatrics3030048. Review.

9.

Health related quality of life in older patients with solid tumors and prognostic factors for decline.

Decoster L, Quinten C, Kenis C, Flamaing J, Debruyne PR, De Groof I, Focan C, Cornelis F, Verschaeve V, Bachmann C, Bron D, Luce S, Debugne G, den Bulck, Goeminne JC, Baitar A, Geboers K, Petit B, Langenaeken C, Van Rijswijk R, Specenier P, Jerusalem G, Praet JP, Vandenborre K, Lobelle JP, Lycke M, Milisen K, Wildiers H.

J Geriatr Oncol. 2019 Apr 17. pii: S1879-4068(18)30373-4. doi: 10.1016/j.jgo.2019.03.018. [Epub ahead of print]

PMID:
31005649
10.

Shifting specialized oncological care from hospital- to home-setting: is there support among patients, specialists and general practitioners?

Cool L, Brewaeys C, Viaene S, Missiaen J, Lycke M, Lefebvre T, Tack L, Foulon V, Pottel H, Debruyne P, Vandijck D, Van Eygen K.

Acta Clin Belg. 2019 Apr 19:1-8. doi: 10.1080/17843286.2019.1605467. [Epub ahead of print]

PMID:
31003594
11.

Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study.

Cho BC, DE Pas T, Kalofonos H, Wang Q, Ramlau R, Cheng Y, Vitiello F, Laisaar T, Vallières E, Kubisa B, Orlov S, Park K, Debruyne C, Vansteenkiste J.

Anticancer Res. 2019 Mar;39(3):1403-1409. doi: 10.21873/anticanres.13255.

PMID:
30842175
12.

Detection of alcohol abuse in older patients with cancer: The integration of alcohol screening questionnaires in the comprehensive geriatric assessment.

Lycke M, Martens E, Ketelaars L, Dezutter J, Lefebvre T, Pottel H, Van Eygen K, Cool L, Schofield P, Boterberg T, Debruyne PR.

J Geriatr Oncol. 2019 Feb 26. pii: S1879-4068(18)30281-9. doi: 10.1016/j.jgo.2019.02.009. [Epub ahead of print]

PMID:
30824223
13.

Subjective, but not objective, cognitive complaints impact long-term quality of life in cancer patients.

Lycke M, Lefebvre T, Pottel L, Pottel H, Ketelaars L, Stellamans K, Van Eygen K, Vergauwe P, Werbrouck P, Cool L, Boterberg T, Liefhooghe N, Schofield P, Debruyne PR.

J Psychosoc Oncol. 2019 Jul-Aug;37(4):427-440. doi: 10.1080/07347332.2018.1504154. Epub 2019 Feb 23.

PMID:
30798774
14.

The relation between goal adjustment, goal disturbance, and mental well-being among persons with multiple sclerosis.

Van Damme S, Kindt S, Crombez G, Goubert L, Debruyne J.

Psychol Health. 2019 Jun;34(6):645-660. doi: 10.1080/08870446.2018.1556272. Epub 2019 Jan 26.

PMID:
30688085
15.

The added value of an assessment of the patient's hand grip strength to the comprehensive geriatric assessment in G8-abnormal older patients with cancer in routine practice.

Lycke M, Ketelaars L, Martens E, Lefebvre T, Pottel H, Van Eygen K, Cool L, Pottel L, Kenis C, Schofield P, Boterberg T, Debruyne PR.

J Geriatr Oncol. 2019 Jan 10. pii: S1879-4068(18)30125-5. doi: 10.1016/j.jgo.2019.01.001. [Epub ahead of print]

PMID:
30639266
16.

Letter by Debruyne regarding article "Selective ablation of atrial ganglionated plexus attenuates vasovagal reflex in a canine model".

Debruyne P.

Pacing Clin Electrophysiol. 2019 Mar;42(3):390. doi: 10.1111/pace.13597. Epub 2019 Jan 14. No abstract available.

PMID:
30609071
17.

Chemoenzymatic Approach toward the Synthesis of 3-O-(α/β)-Glucosylated 3-Hydroxy-β-lactams.

Decuyper L, Franceus J, Dhaene S, Debruyne M, Vandoorne K, Piens N, Dewitte G, Desmet T, D'hooghe M.

ACS Omega. 2018 Nov 30;3(11):15235-15245. doi: 10.1021/acsomega.8b01969. Epub 2018 Nov 12.

18.

Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib.

Vanmechelen M, Lambrechts D, Van Brussel T, Verbiest A, Couchy G, Schöffski P, Dumez H, Debruyne PR, Lerut E, Machiels JP, Richard V, Albersen M, Verschaeve V, Oudard S, Méjean A, Wolter P, Zucman-Rossi J, Beuselinck B.

Clin Genitourin Cancer. 2019 Apr;17(2):e235-e246. doi: 10.1016/j.clgc.2018.11.002. Epub 2018 Nov 16.

PMID:
30527746
19.

Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery.

Quinten C, Kenis C, Decoster L, Debruyne PR, De Groof I, Focan C, Cornelis F, Verschaeve V, Bachmann C, Bron D, Luce S, Debugne G, Van den Bulck H, Goeminne JC, Baitar A, Geboers K, Petit B, Langenaeken C, Van Rijswijk R, Specenier P, Jerusalem G, Praet JP, Vandenborre K, Lycke M, Flamaing J, Milisen K, Lobelle JP, Wildiers H.

Qual Life Res. 2019 Mar;28(3):663-676. doi: 10.1007/s11136-018-2062-6. Epub 2018 Dec 3.

PMID:
30511255
20.

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.

van der Leest M, Cornel E, Israël B, Hendriks R, Padhani AR, Hoogenboom M, Zamecnik P, Bakker D, Setiasti AY, Veltman J, van den Hout H, van der Lelij H, van Oort I, Klaver S, Debruyne F, Sedelaar M, Hannink G, Rovers M, Hulsbergen-van de Kaa C, Barentsz JO.

Eur Urol. 2019 Apr;75(4):570-578. doi: 10.1016/j.eururo.2018.11.023. Epub 2018 Nov 23.

Supplemental Content

Loading ...
Support Center